Plus 5 New Strong Buys for Today
[Kevin Matras]
Profit from the Pros
By Kevin Matras
Executive Vice President [Zacks Investment Research]
Stocks Soar On Positive News For Virus Treatment, Earnings, And Reopening Economy
Image: Bigstock
Stocks soared yesterday on encouraging test results for a treatment on the coronavirus.
Reports that Gilead's drug Remdesivir performed well in a controlled study lifted the market. That news was cheered as it gets us one step closer to beating the virus. And it will eventually give those who may be apprehensive of going back outside the added confidence to go out in public and resume their normal lives.
The results were especially sweet after the World Health Organization (WHO) last week 'accidentally' published a flawed Chinese study claiming the drug failed. Gilead said that the WHO's accidental post included "inappropriate characterizations of the study." And the WHO apologized afterwards. But I remarked at the time that it felt like somebody was trying to manipulate the stock. I'm even more convinced of that now.
Either way, glad the good news came out. That lifted the stock, and people's spirits too.
Let me also note that in addition to Gilead's drug trials, there's currently 72 other trials of different therapeutics going on right now, and 211 trials that are in the planning stages. So the race is on for a cure. And sooner or later, we'll get one (or a few).
Stocks also climbed on earnings optimism. Google jumped nearly 9% yesterday after reporting better than expected top line results the day before. That optimism spilled over to upcoming earnings. And that was not misplaced. After the close yesterday, the market applauded Microsoft's results, Tesla's results, and Facebook's results with each one up 3.5%, 9.9%, and 10.2% respectively in after-hours trade. And that was on top of the stellar gains they had in the regular session leading up to it.
Today we'll get results from Twitter (before the market opens), Amazon (after the close), and Apple (after the close).
The market also liked what it heard from the Fed. They pledged to keep interest rates near zero until the economy gets back to full employment and inflation returns. And they will continue to buy Treasuries and mortgage-backed securities until they reach their price stability goals.
Yesterday morning's Q1 GDP report showing the economy contracted by -4.8% was quickly dismissed as 'old news.' Everybody knew it was going to be bad. And it was. But as I've said before, the market is forward looking, and the focus has shifted to reopening our economy. And when America gets back to work, the new numbers will look nothing like what we saw at our worst.
That's why stocks have been soaring.
And even though we've seen a spectacular rally so far, it looks like there's a lot more upside to go.
A lot of the stocks people bought in the last few weeks at bargain basement prices will likely turn out to be long-term holds. Especially if they were combined with strong fundamentals.
And there's nothing like sitting back and watching the gains rack up. But too many long-term investors see their hopes dashed when their once promising investment turns sour and they scramble to cut losses.
Don't be that person.
Finding long-term core holdings that you can buy and hold and effortlessly cash in when the time comes is an investor's dream. If you want to live that dream right, be sure to read our latest commentary...
[Avoiding the 3 Pitfalls of 'Buy & Hold' Investing](
Best,
Kevin Matras
Executive Vice President, Zacks Investment Research
Sponsor
[FREE Report: The Coronavirus Playbook... How You Can Double Your Profits with These Healthcare Stocks](
Discover:
The little-known company developing a drug designed to treat and prevent coronavirus.
The group of "unstoppable" stocks you need in your portfolio right now.
How to turn the stock market downturn to your advantage.
PLUS critical research on coronavirus that will help keep your health and wealth intact.
[Yours Free](
Most Popular Articles from Zacks.com
Image: Bigstock
[Cloud Business Soars as Coronavirus Fuels Work & Learn From Home](
Google Cloud's growing business in the commercial and public sectors was the only bright spot in an otherwise mixed quarter. [Read More »](
Image: Bigstock
[5 Top Growth Stocks Rallying More Than 25% in Lockdown April](
We have narrowed down our search to five stocks with a Growth Score of A that have skyrocketed in April. [Read More »](
Image: Bigstock
[Outlook for Internet Delivery Services Industry Appears Bright](
Higher Internet presence in emerging markets, a burgeoning affluent middle class and the accelerated uptake of smartphones will help the participants in the industry. [Read More »](
Image: Bigstock
[Tech Majors Report Earnings After the Bell: MSFT, FB, TSLA & More](
Facebook misses by a penny but races ahead, Microsoft posts its latest beat, plus much more. [Read More »](
Image: Bigstock
[Who Will Win in the New Era of Retail?](
The coronavirus is upending the retail industry in 2020. Companies that embrace new technologies will come out on top. [Read More »](
Sponsor
[Notification of Release: 5 Stocks Set to Double](
Five Zacks' experts each revealed their single favorite stock with the best chance to gain +100% and more in the months ahead. For example, one is an Internet service with surging earnings, double-digit 2019 sales increase and rampantly growing user base.
Today, you are invited to download the just-released Special Report that names these stocks and spotlights why their gain potential is so exceptional.
[See Stocks Now >>](
Image: Bigstock
[Bull of the Day: The Scotts Miracle-Gro Company (SMG)](
Shares have surged 20% in 2020, with its lawn care products seen as immune from the coronavirus. [Read More »](
[New Zacks Strong Buys for April 30th](
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. [Read More »](
Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.
[Download our Zacks App for Apple iOS](
[Download our Zacks App for Android](
Visit [Success Stories]( to hear how Zacks research, tools and portfolios help our members outperform the market.
Get all of our market insights and much more when you connect with us.
[Visit Zacks on Facebook]( [Follow Zacks on Twitter]( [See Zacks videos on YouTube]( [Join Zacks on LinkedIn]( [Read Zacks Commentary on StockTwits](
This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. [www.zacks.com/disclaimer](.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through March 2, 2020. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above.
Zacks Emails
If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.
Zacks Investment Research
10 S. Riverside Plaza, Suite 1600
Chicago, IL 60606